Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03DNI
|
|||
| Former ID |
DIB004373
|
|||
| Drug Name |
Hepatitis C virus E2 protein vaccines
|
|||
| Synonyms |
HCV E2 protein vaccines, XTL; Hepatitis C virus E2 protein vaccines, XTL
Click to Show/Hide
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Terminated | [1] | |
| Company |
XTL Biopharmaceuticals Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.J Virol. 2000 Aug;74(15):6885-92. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.